QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.26%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.26%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.26%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.26%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
NASDAQ:IMAC

IMAC - IMAC Stock Forecast, Price & News

$0.61
+0.01 (+1.68%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.59
$0.61
50-Day Range
$0.61
$1.05
52-Week Range
$0.75
$1.65
Volume
273,507 shs
Average Volume
708,132 shs
Market Capitalization
$16.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.02

IMAC MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
398.0% Upside
$3.02 Price Target
Short Interest
Healthy
0.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.43mentions of IMAC in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.34) to ($0.32) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars

Medical Sector

919th out of 1,122 stocks

Specialty Outpatient Clinics, Not Elsewhere Classified Industry

2nd out of 3 stocks

IMAC stock logo

About IMAC (NASDAQ:IMAC) Stock

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

IMAC Stock Performance

Shares of NASDAQ:IMAC traded down $0.04 during midday trading on Wednesday, hitting $0.60. 889,750 shares of the company's stock were exchanged, compared to its average volume of 708,132. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.27 and a quick ratio of 1.27. IMAC has a twelve month low of $0.75 and a twelve month high of $1.65. The firm's fifty day simple moving average is $0.93 and its 200-day simple moving average is $0.97.

Wall Street Analyst Weigh In

Separately, Ascendiant Capital Markets cut their target price on IMAC to $5.50 and set a "na" rating on the stock in a research report on Monday, May 16th.

Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Stock News Headlines

The Back Company demonstrates strong Q2 growth
See More Headlines
Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Company Calendar

Last Earnings
4/14/2022
Today
8/17/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Specialty outpatient clinics, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IMAC
Fax
N/A
Employees
106
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.02
High Stock Price Forecast
$5.50
Low Stock Price Forecast
$1.75
Forecasted Upside/Downside
+398.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-10,540,000.00
Pretax Margin
-75.40%

Debt

Sales & Book Value

Annual Sales
$14.39 million
Book Value
$0.69 per share

Miscellaneous

Free Float
23,837,000
Market Cap
$16.04 million
Optionable
Not Optionable
Beta
-0.88














IMAC Stock - Frequently Asked Questions

Should I buy or sell IMAC stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IMAC in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" IMAC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMAC, but not buy additional shares or sell existing shares.
View IMAC analyst ratings
or view top-rated stocks.

What is IMAC's stock price forecast for 2022?

3 analysts have issued twelve-month price targets for IMAC's stock. Their IMAC share price forecasts range from $1.75 to $5.50. On average, they expect the company's stock price to reach $3.02 in the next year. This suggests a possible upside of 398.0% from the stock's current price.
View analysts price targets for IMAC
or view top-rated stocks among Wall Street analysts.

How have IMAC shares performed in 2022?

IMAC's stock was trading at $1.14 on January 1st, 2022. Since then, IMAC shares have decreased by 46.9% and is now trading at $0.6057.
View the best growth stocks for 2022 here
.

How were IMAC's earnings last quarter?

IMAC Holdings, Inc. (NASDAQ:IMAC) announced its quarterly earnings data on Thursday, April, 14th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.09) by $0.03. IMAC had a negative trailing twelve-month return on equity of 52.17% and a negative net margin of 75.40%.

What other stocks do shareholders of IMAC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include VBI Vaccines (VBIV), Biocept (BIOC), Energy Transfer (ET), iBio (IBIO), McEwen Mining (MUX), OPKO Health (OPK), Advanced Micro Devices (AMD), Amarin (AMRN), Aytu BioPharma (AYTU) and Bionano Genomics (BNGO).

When did IMAC IPO?

(IMAC) raised $4 million in an initial public offering on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

What is IMAC's stock symbol?

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

Who are IMAC's major shareholders?

IMAC's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Nantahala Capital Management LLC (4.76%), Resources Investment Advisors LLC. (0.45%), Virtu Financial LLC (0.25%), IAM Advisory LLC (0.17%) and State Street Corp (0.15%). Insiders that own company stock include Jeffrey S Ervin, Matthew C Wallis and Michael D Pruitt.
View institutional ownership trends
.

How do I buy shares of IMAC?

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IMAC's stock price today?

One share of IMAC stock can currently be purchased for approximately $0.61.

How much money does IMAC make?

IMAC (NASDAQ:IMAC) has a market capitalization of $16.04 million and generates $14.39 million in revenue each year.

How many employees does IMAC have?

The company employs 106 workers across the globe.

How can I contact IMAC?

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The official website for the company is www.imacregeneration.com. The company can be reached via phone at (844) 266-4622 or via email at brets@coreir.com.

This page (NASDAQ:IMAC) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.